Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrated Phenotypic-Genotypic Surveillance of Neuraminidase Inhibitor Susceptibility in Influenza A(H1N1), A(H3N2), and B/Victoria Viruses in Saudi Arabia, 2024-2025.

Journal of medical virology - 1 Jan 2026

Naeem Asif, Hakami Maymunah, Aljami Haya, Almiqbel Haneen S, Alzahrani Nabeel, Aljohani Sameera, Bosaeed Mohammed

Abstract excerpt

Contemporary neuraminidase inhibitor (NAI) surveillance data from the Middle East are limited. We profiled current-season susceptibility among influenza A(H1N1), A(H3N2), and B/Victoria viruses circulating in Saudi Arabia (2024-2025) using paired phenotypic and genotypic methods. Respiratory specimens underwent virus isolation and neuraminidase-inhibition testing with the NA-XTD™ chemiluminescent assay kit...

Topics

Join the communities discussing this publication.

Cyclopentanes
Guanidines
Influenza A Virus, H1N1 Subtype
Influenza A Virus, H3N2 Subtype
Influenza B virus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 41527997
DOI: 10.1002/jmv.70796

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrated Phenotypic-Genotypic Surveillance of Neuraminidase Inhibitor Susceptibility in Influenza A(H1N1), A(H3N2), and B/Victoria Viruses in Saudi Arabia, 2024-2025.PMID 41527997Read ↗

Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Circulating Globally in 2022-2023.Semantic proximity Read ↗

Molecular surveillance of influenza A virus in Saudi Arabia: whole-genome sequencing and metagenomic approachesSemantic proximity Read ↗

Genetic Characterization of Influenza A (A/H3N2) Viruses Reveals Antigenic Drift in Receptor Binding Domain and Possible Vaccine Mismatch in Strains Circulating in Riyadh, Saudi Arabia, 2024-2025Semantic proximity Read ↗

Antiviral Susceptibility of Influenza A(H5N1) Clade 2.3.2.1c and 2.3.4.4b Viruses from Humans, 2023–2024Semantic proximity Read ↗

Influenza neuraminidase mutations and resistance to neuraminidase inhibitors.Semantic proximity Read ↗

Genetic variation and vaccine match of influenza B virus in Riyadh, Saudi Arabia during three consecutive seasons, 2020-2023.Semantic proximity Read ↗

Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023-February 2024.Semantic proximity Read ↗

Genotypic and phenotypic susceptibility of emerging avian influenza A viruses to neuraminidase and cap-dependent endonuclease inhibitors.Semantic proximity Read ↗

Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses isolated from birds and mammals in the United States, 2022Semantic proximity Read ↗

Evolutionary Characteristic of Global H1N1 Influenza A Viruses With Oseltamivir Resistance From 1918 to 2024Semantic proximity Read ↗

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.Semantic proximity Read ↗

Genomic Variability in the Neuraminidase Gene and Antiviral Resistance of Influenza A(H1N1)pdm09 Virus Isolated from Acute Respiratory Infection Patients in Shiraz, Iran (2023–2024)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.